Fund Holdings — Paradigm Biocapital Advisors LP

Total Portfolio Value
$3.38B
Total Bought
$1.11B
Total Sold
$314.55M
Net Transaction
+$792.81M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
MERUS N V4,281,9544,373,770+91,816225,231411,79012.18%+186,560
ABIVAX SA(ABVX)01,564,196+1,564,1960132,8003.93%+132,800
GENMAB A/S(GMAB)03,816,851+3,816,8510117,0633.46%+117,063
CIDARA THERAPEUTICS INC0961,164+961,164092,0412.72%+92,041
UROGEN PHARMA LTD(URGN)04,216,084+4,216,084084,1112.49%+84,111
ARCELLX INC
COMMON STOCK
4,649,0164,649,0160306,138381,68411.29%+75,547
AGIOS PHARMACEUTICALS INC(AGIO)1,142,5112,673,555+1,531,04438,000107,3163.18%+69,317
REVOLUTION MEDICINES INC(RVMD)6,093,2916,223,291+130,000224,172290,6288.60%+66,456
NUVALENT INC5,269,4335,269,4330402,058455,70113.48%+53,643
CRINETICS PHARMACEUTICALS IN(CRNX)2,343,5532,550,774+207,22167,401106,2403.14%+38,839
TARSUS PHARMACEUTICALS INC(TARS)2,976,0992,665,698-310,401120,562158,4224.69%+37,861
OLEMA PHARMACEUTICALS INC(OLMA)6,764,1726,794,172+30,00028,81566,5151.97%+37,700
EYEPOINT PHARMACEUTICALS INC(EYPT)02,005,365+2,005,365028,5560.84%+28,556
PHARVARIS N V
COM
1,062,9111,835,494+772,58318,70745,7961.36%+27,088
VAXCYTE INC(PCVX)3,372,8373,784,755+411,918109,651136,3274.03%+26,676
TANGO THERAPEUTICS INC(TNGX)03,086,184+3,086,184025,9240.77%+25,924
AMYLYX PHARMACEUTICALS INC(AMLX)01,900,000+1,900,000025,8210.76%+25,821
DYNE THERAPEUTICS INC(DYN)01,898,950+1,898,950024,0220.71%+24,022
BRIDGEBIO ONCOLOGY THERAPEUT(BBOT)01,866,141+1,866,141021,6100.64%+21,610
EDGEWISE THERAPEUTICS INC(EWTX)6,142,3446,170,131+27,78780,526100,0802.96%+19,553
APOGEE THERAPEUTICS INC(APGE)958,6301,521,757+563,12741,63360,4591.79%+18,826
SCHOLAR ROCK HLDG CORP(SRRK)1,600,5542,009,745+409,19156,69274,8432.21%+18,151
VIRIDIAN THERAPEUTICS INC(VRDN)2,741,5762,609,353-132,22338,32756,3101.67%+17,983
ERASCA INC(ERAS)11,907,18213,560,017+1,652,83515,12229,5610.87%+14,439
ALKERMES PLC(ALKS)1,375,5691,719,334+343,76539,35551,5801.53%+12,225
STRUCTURE THERAPEUTICS INC0372,869+372,869010,4400.31%+10,440
OCULAR THERAPEUTIX INC(OCUL)3,420,3403,497,307+76,96731,74140,8841.21%+9,143
JANUX THERAPEUTICS INC(JANX)2,920,2582,920,258067,45871,3712.11%+3,913
LENZ THERAPEUTICS INC(LENZ)1,717,0661,073,461-643,60550,32750,0021.48%-325
SPYRE THERAPEUTICS INC(SYRE)1,870,4451,467,266-403,17928,00124,5910.73%-3,409
BRIDGEBIO PHARMA INC(BBIO)965,764684,277-281,48741,70235,5411.05%-6,160
CRESCENT BIOPHARMA INC.(CBIO)642,7210-642,72110,3740—-10,374
IMMATICS N.V(IMTX)3,144,1570-3,144,15716,9160—-16,916
Y-MABS THERAPEUTICS INC4,236,3460-4,236,34619,1060—-19,106
COGENT BIOSCIENCES INC(COGT)10,352,4493,156,398-7,196,05174,33145,3261.34%-29,005
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)878,3230-878,32341,4570—-41,457
DISC MEDICINE INC(IRON)1,210,971247,716-963,25564,13316,3690.48%-47,764
BEONE MEDICINES LTD(ONC)347,7870-347,78784,1890—-84,189
Page 1 of 1
Paradigm Biocapital Advisors LP — 13F Holdings — Q3 2025 | TickerTrail